Taro Pharmaceutical Industries Ltd. (TARO): Price and Financial Metrics

TARO POWR Grades

• Sentiment is the dimension where TARO ranks best; there it ranks ahead of 90.75% of US stocks.
• TARO's strongest trending metric is Momentum; it's been moving up over the last 178 days.
• TARO's current lowest rank is in the Momentum metric (where it is better than 24.4% of US stocks).

TARO Stock Summary

• The ratio of debt to operating expenses for TARO PHARMACEUTICAL INDUSTRIES LTD is higher than it is for about only 0.52% of US stocks.
• TARO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 15.59% of US stocks.
• Over the past twelve months, TARO has reported earnings growth of -1,171.59%, putting it ahead of only 1.31% of US stocks in our set.
• If you're looking for stocks that are quantitatively similar to TARO PHARMACEUTICAL INDUSTRIES LTD, a group of peers worth examining would be UPC, WAVE, CNEY, RLX, and FALC.
• TARO's SEC filings can be seen here. And to visit TARO PHARMACEUTICAL INDUSTRIES LTD's official web site, go to www.taro.com.

TARO Valuation Summary

• TARO's price/earnings ratio is 17; this is 26.72% lower than that of the median Healthcare stock.
• TARO's price/sales ratio has moved down 0.3 over the prior 243 months.

Below are key valuation metrics over time for TARO.

TARO Growth Metrics

Its 5 year revenue growth rate is now at -32.18%.
• The 5 year net income to common stockholders growth rate now stands at -54.85%.
• Its year over year net income to common stockholders growth rate is now at -258.31%.

TARO's revenue has moved down $384,320,000 over the prior 70 months.

The table below shows TARO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	566.431	-148.901	1.077
2021-09-30	567.592	85.894	7.683
2021-06-30	578.449	25.653	29.498
2021-03-31	548.97	45.77	-386.653
2021-03-31	548.97	45.77	-386.653
2020-12-31	575.562	NA	-302.671

TARO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• TARO has a Quality Grade of B, ranking ahead of 81% of graded US stocks.
• TARO's asset turnover comes in at 0.239 -- ranking 182nd of 682 Pharmaceutical Products stocks.
• ELTP, ADMP, and ENTA are the stocks whose asset turnover ratios are most correlated with TARO.

The table below shows TARO's key quality metrics over time.